{"entity":{"type":"insider","cik":"0001398940","url":"/insider/0001398940","json_url":"/insider/0001398940.json","name":"MOLINA ARTURO MD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":11,"first":"2020-05-14","last":"2026-03-27","span_basis":"filed_date"},"name_variants":[{"name":"MOLINA ARTURO MD","source":"filing","n_filings":11,"first_seen":"2020-05-14","last_seen":"2026-03-27"}],"transactions":[{"id":6109494,"accession":"0001104659-26-036319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-036319","line_url":"/filing/0001104659-26-036319#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":104.79,"price_display":"104.79","price_state":"stated","total_value":1571850.0,"total_display":"1,571,850.00","total_whole":"1,571,850","shares_owned_after":84115.0,"shares_owned_after_display":"84,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-27","scope":"insider"},{"id":5915751,"accession":"0001104659-26-007127","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-007127","line_url":"/filing/0001104659-26-007127#line-5","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":82.0,"price_display":"82.00","price_state":"stated","total_value":410000.0,"total_display":"410,000.00","total_whole":"410,000","shares_owned_after":84115.0,"shares_owned_after_display":"84,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-27","filed_date":"2026-01-27","scope":"insider"},{"id":5915747,"accession":"0001104659-26-007127","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-007127","line_url":"/filing/0001104659-26-007127#line-3","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":82.28,"price_display":"82.28","price_state":"stated","total_value":411400.0,"total_display":"411,400.00","total_whole":"411,400","shares_owned_after":84115.0,"shares_owned_after_display":"84,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-27","scope":"insider"},{"id":5915742,"accession":"0001104659-26-007127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-007127","line_url":"/filing/0001104659-26-007127#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13151.0,"shares_display":"13,151","price_per_share":82.42,"price_display":"82.42","price_state":"stated","total_value":1083905.42,"total_display":"1,083,905.42","total_whole":"1,083,905","shares_owned_after":84115.0,"shares_owned_after_display":"84,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-01-27","scope":"insider"},{"id":5833279,"accession":"0001104659-26-005443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-005443","line_url":"/filing/0001104659-26-005443#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9514.0,"shares_display":"9,514","price_per_share":82.48,"price_display":"82.48","price_state":"stated","total_value":784714.72,"total_display":"784,714.72","total_whole":"784,715","shares_owned_after":97266.0,"shares_owned_after_display":"97,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":4469639,"accession":"0001104659-25-114082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-114082","line_url":"/filing/0001104659-25-114082#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2712.0,"shares_display":"2,712","price_per_share":84.77,"price_display":"84.77","price_state":"stated","total_value":229896.24,"total_display":"229,896.24","total_whole":"229,896","shares_owned_after":81180.0,"shares_owned_after_display":"81,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":4469358,"accession":"0001104659-25-058597","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-058597","line_url":"/filing/0001104659-25-058597#line-4","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":57.03,"price_display":"57.03","price_state":"stated","total_value":570300.0,"total_display":"570,300.00","total_whole":"570,300","shares_owned_after":83892.0,"shares_owned_after_display":"83,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-11","scope":"insider"},{"id":4469351,"accession":"0001104659-25-058597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-058597","line_url":"/filing/0001104659-25-058597#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.51,"price_display":"55.51","price_state":"stated","total_value":555100.0,"total_display":"555,100.00","total_whole":"555,100","shares_owned_after":83892.0,"shares_owned_after_display":"83,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider"},{"id":4347868,"accession":"0001104659-25-024063","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-024063","line_url":"/filing/0001104659-25-024063#line-3","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30514.0,"shares_display":"30,514","price_per_share":55.74,"price_display":"55.74","price_state":"stated","total_value":1700850.36,"total_display":"1,700,850.36","total_whole":"1,700,850","shares_owned_after":83892.0,"shares_owned_after_display":"83,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-14","scope":"insider"},{"id":5083443,"accession":"0001104659-25-004571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-004571","line_url":"/filing/0001104659-25-004571#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3252.0,"shares_display":"3,252","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":83892.0,"shares_owned_after_display":"83,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":5083437,"accession":"0001104659-25-004571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-004571","line_url":"/filing/0001104659-25-004571#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":388.0,"shares_display":"388","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":87144.0,"shares_owned_after_display":"87,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":2052054,"accession":"0001104659-24-123809","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-24-123809","line_url":"/filing/0001104659-24-123809","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":44.70307692307692,"price_display":"44.70","price_state":"stated","total_value":1162280.0,"total_display":"1,162,280.00","total_whole":"1,162,280","shares_owned_after":46444.0,"shares_owned_after_display":"46,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-11-27","scope":"insider","n_lines":2},{"id":2052047,"accession":"0001104659-24-123809","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-123809","line_url":"/filing/0001104659-24-123809#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5529.0,"shares_display":"5,529","price_per_share":45.6,"price_display":"45.60","price_state":"stated","total_value":252122.4,"total_display":"252,122.40","total_whole":"252,122","shares_owned_after":46444.0,"shares_owned_after_display":"46,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-27","scope":"insider"},{"id":2035555,"accession":"0001104659-24-120670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-120670","line_url":"/filing/0001104659-24-120670#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1906.0,"shares_display":"1,906","price_per_share":40.98,"price_display":"40.98","price_state":"stated","total_value":78107.88,"total_display":"78,107.88","total_whole":"78,108","shares_owned_after":46444.0,"shares_owned_after_display":"46,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-19","scope":"insider"},{"id":2085460,"accession":"0001104659-24-001490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-001490","line_url":"/filing/0001104659-24-001490#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1848.0,"shares_display":"1,848","price_per_share":16.24,"price_display":"16.24","price_state":"stated","total_value":30011.52,"total_display":"30,011.52","total_whole":"30,012","shares_owned_after":22527.0,"shares_owned_after_display":"22,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2024-01-04","scope":"insider"},{"id":2543802,"accession":"0001209191-20-029244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-029244","line_url":"/filing/0001209191-20-029244#line-1","is_derivative":false,"issuer_cik":"0001382101","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001382101","owner_cik":"0001398940","owner_name":"MOLINA ARTURO MD","owner_display_name":"MOLINA ARTURO MD","owner_url":"/insider/0001398940","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6451.0,"shares_display":"6,451","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":49995.25,"total_display":"49,995.25","total_whole":"49,995","shares_owned_after":12083.0,"shares_owned_after_display":"12,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-14","filed_date":"2020-05-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Officer (Chief Medical Officer)","n_filings":10,"first_seen":"2024-01-04","last_seen":"2026-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001382101","name":"SUTRO BIOPHARMA, INC.","url":"/issuer/0001382101","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2020-05-14","last_seen":"2020-05-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001398940","retrieved_at":"2026-08-22T08:22:47+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}